🇺🇸 FDA
Pipeline program

levothyroxine sodium

XP-8121-120

Phase 2 small_molecule completed

Quick answer

levothyroxine sodium for Hypothyroidism is a Phase 2 program (small_molecule) at Xeris Biopharma Holdings with 1 ClinicalTrials.gov record(s).

Program details

Company
Xeris Biopharma Holdings
Indication
Hypothyroidism
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials